Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Pharmala Biotech Holdings Inc.
No Price
Closing Price XCNQ 01.05.2026:
0,14 CAD
01.05.2026 19:59
Current Prices from Pharmala Biotech Holdings Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
CSE LISTED
MDMA.CN
CAD
01.05.2026 19:59
0,14 CAD
0,00 CAD
Share Float & Liquidity
Free Float90,97 %
Shares Float99,05 M
Shares Outstanding108,89 M
Company Profile for Pharmala Biotech Holdings Inc. Share
Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.
